Structure-activity studies on high affinity NOP-active hexapeptides

Journal of Peptide Research

Volumn 64, Issue 3, 2004, Pages 87-94

  Judd, A K ^a   Tuttle, D J ^a   Jones, R W ^a   Sanchez, A ^b   Polgar, W ^c   Berzetei Gurske, I ^c   Toll, L ^c  

^a SynVax Inc   (United States)

^b STANFORD UNIVERSITY   (United States)

^c SRI INTERNATIONAL   (United States)

Author keywords

Affinity; Agonists; Antagonists; Nociceptin; Opioid receptor like 1, NOP; Peptides

Indexed keywords

ACETYLARGINYLTYROSYLTYROSYLARGINYLTRYPTOPHYLARGININAMIDE; AMINO ACID; HEXAPEPTIDE; HYDROXYL GROUP; NOCICEPTIN; NOCICEPTIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

ANIMALS; ARGININE; CHO CELLS; CRICETINAE; DNA, COMPLEMENTARY; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KINETICS; LIGANDS; MALE; MICE; OLIGOPEPTIDES; OPIOID PEPTIDES; RECEPTORS, OPIOID; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TYROSINE; VAS DEFERENS;

ANIMALIA;

EID: 4444342650     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2004.00169.x     Document Type: Article

References (39)

1. Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monsarrat, B., Mazarguil, H., Vassart, G., Parmentier, M. & Costentin, J. (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
2. Reinscheid, R.K., Nothacker, H.P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. Jr & Civelli, O. (1995) Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270, 792-794.
3. Calo, G., Guerrini, R., Rizzi, A., Salvadori, S. & Regoli, D. (2000) Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129, 1261-1283.
4. Reinscheid, R.K., Ardati, A., Monsma, F.J. Jr & Civelli, O. (1996) Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem. 271, 14163-14168.
5. Dooley, C.T. & Houghten, R.A. (1996) Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci. 59, 23-29.
6. Goldstein, A. (1984) Opioid peptides: function and significance. In: Opioids: Past, Present, and Future (Hughes, J., Collier, H.O.J., Ranee, M.J. & Tyers, M.B., eds), pp. 127-143. Taylor & Frances Ltd, London.
7. Guerrini, R., Calo, G., Rizzi, A., Bigoni, R., Rizzi, D., Regoli, D. & Salvadori, S. (2000) Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A. Peptides 21, 923-933.
8. Guerrini, R., Calo, G., Rizzi, A., Bigoni, R., Bianchi, C., Salvadori, S. & Regoli, D. (1998) A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123, 163-165.
9. Butour, J.L., Moisand, C., Mollereau, C. & Meunier, J.C. (1998) [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol. 349, R5-R6.
10. Calo, G., Rizzi, A., Marzola, G., Guerrini, R., Salvadori, S., Beani, L., Regoli, D. & Bianchi, C. (1998) Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol. 125, 373-378.
11. Grisel, J.E., Farrier, D.E., Wilson, S.G. & Mogil, J.S. (1998) [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur. J. Pharmacol. 357, R1-R3.
12. Chu, X., Xu, N., Li, P., Mao, L. & Wang, J.Q. (1999) Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla. Brain Res. 829, 134-142.
13. Calo, G., Rizzi, A., Rizzi, D., Bigoni, R., Guerrini, R., Marzola, G., Marti, M., McDonald, J., Morari, M., Lambert, D.G., Salvadori, S. & Regoli, D. (2002) [Nphe(1),Arg(14),Lys(15)]nociceptin-NH(2), a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br. J. Pharmacol. 136, 303-311.
14. Dooley, C.T., Spaeth, C.G., Berzetei-Gurske, I.P., Craymer, K., Adapa, I.D., Brandt, S.R., Houghten, R.A. & Toll, L. (1997) Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J. Pharmacol. Exp. Ther. 283, 735-741.
15. Judd, A.K., Kaushanskaya, A., Tuttle, D.J., Sanchez, A., Khroyan, T., Polgar, W. & Toll, L. (2003) N-terminal modifications leading to peptide ORL1 partial agonists and antagonists. J. Pept. Res. 62, 191-198.
16. Adapa, D.I. & Toll, L. (1997) Relationship between binding affinity and functional activity of nociceptin/orphanin FQ. Life Sci. 31, 403-408.
17. Cheng, Y.-C. & Prusoff, W.H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
18. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47, 848-854.
19. Hughes, J.H., Kosterlitz, H.W. & Leslie, F.M. (1975) Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br. J. Pharmacol. 53, 371-381.
20. Ronai, A.Z., Graf, L.J.I., Szekely, J.I., Dunai-Kovacs, Z. & Bajusz, S. (1977) Differential behaviour of LPH-(61-69)-peptide in different model systems: comparison of the opioid activities of LPH-(61-91)-peptide and its fragments. FEBS Lett. 74, 182-184.
21. Berzetei-Gurske, I.P., Schwartz, R.W. & Toll, L. (1996) Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmacol. 302, R1-R2.
22. Janik, J., Krupica, T., Dengler, L., Murphree, E. & Callahan, P. (2003) Acetyl-RYYRIK-NH2, a purported orphanin FQ antagonist, does not block the orphanin FQ-induced prolactin secretory response in female rats. Neurosci. Lett. 345, 149-152.
23. Malinowska, B., Kozlowska, H., Berger, H. & Schlicker, E. (2000) Acetyl-RYYRIK-NH(2) is a highly efficacious OP(4) receptor agonist in the cardiovascular system of anesthetized rats. Peptides 21, 1875-1880.
24. Ho, M., Corbett, A.D. & McKnight, A.T. (2000) Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle. Br. J. Pharmacol. 131, 349-355.
25. Chiou, L.C. (2000) Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray. J. Biomed. Sci. 7, 232-240.
26. Berger, H., Albrecht, E., Wallukat, G. & Bienert, M. (1999) Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br. J. Pharmacol. 126, 555-558.
27. Chavkin, C.A.A.G. (1981) Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. U S A 78, 6543-6547.
28. Mogil, J.S. & Pasternak, G.W. (2001) The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53, 381-415.
29. Zaveri, N. (2003) Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci. 73, 663-678.
30. Burnside, J.L., Rodriguez, L. & Toll, L. (2000) Species differences in the efficacy of compounds at the nociceptin receptor (ORL1). Peptides 21, 1147-1154.
31. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.L., Moisand, C., Chalon, P., Caput, D., Vassart, G. & Meunier, J.C. (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341, 33-38.
32. Mogil, J.S., Grisel, J.E., Zhangs, G., Belknap, J.K. & Grandy, D.K. (1996) Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214, 131-134.
33. Tian, J.H., Xu, W., Fang, Y., Mogil, J.S., Grisel, J.E., Grandy, D.K. & Han, J.S. (1997) Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol. 120, 676-680.
34. Calo, G., Guerrini, R., Bigoni, R., Rizzi, A., Marzola, G., Okawa, H., Bianchi, C., Lambert, D.G., Salvadori, S. & Regoli, D. (2000) Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br. J. Pharmacol. 129, 1183-1193.
35. Ozaki, S., Kawamoto, H., Itoh, Y., Miyaji, M., Azuma, T., Ichikawa, D., Nambu, H., Iguchi, T., Iwasawa, Y. & Ohta, H. (2000) In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist. Eur. J. Pharmacol. 402, 45-53.
36. Yamada, H., Nakamoto, H., Suzuki, Y., Ito, T. & Aisaka, K. (2002) Pharmacological profiles of a novel opioid receptor-like 1 [ORL(1)] receptor antagonist, JTC-801. Br. J. Pharmacol. 135, 323-332.
37. Hao, J.X., Xu, I.S., Wiesenfeld-Hallin, Z. & Xu, X.J. (1998) Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain 76, 385-393.
38. Hara, N., Minami, T., Okuda-Ashitaka, E., Sugimoto, T., Sakai, M., Onaka, M., Mori, H., Imanishi, T., Shingu, K. & Ito, S. (1997) Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmacol. 121, 401-408.
39. Briscini, L., Corradini, L., Ongini, E. & Bertorelli, R. (2002) Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur. J. Pharmacol. 447, 59-65.